The Lancet study said that the Surgisphere data proved that HCQ increased cardiac mortality in COVID-19 patients. Based on this study, the FDA withdrew its EUA recommendation on June 15, 2020,88 the WHO and UK suspended their hydroxychloroquine clinical trials on May 25.89 Each resumed briefly, then stopped for good in June declaring HCQ unhelpful.90 Three European nations immediately banned use of HCQ, and others followed within weeks.91
